BioSpace News Archive

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”) is pleased to announce receipt of The State of Oregon Agriculture Fertilizer Registration Certificate

Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), developer and partner in a wide-range of leading-edge, proprietary diagnostic and medical device technologies

SMC Laboratories, Inc. (“SMC Laboratories”) recently launched their innovative STAM™-HCC/IO+ mouse – a first in the field of tumor immuno-oncology – to develop new liver cancer therapeutic drugs.

Conformal Medical, Inc. announced that the company’s CLAAS® System was featured in a live case presentation during the 29th Annual AF Symposium.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference.

Dementia is a life-changing disease that alters memory, language and other cognitive functions in more than 55 million people worldwide.

Daily exposure to chemicals used in the manufacture of plastic food containers and many cosmetics may be tied to nearly 56,600 preterm births in the U.S. in 2018, a new study shows.

Processa Pharmaceuticals, Inc. announces it has received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on the Nasdaq Market and that the matter is now closed.

Enzymedica is pleased to announce the appointment of Michael Graham as the Vice President of Operations.